DC could soon license pharmaceutical sales reps
Pharma Compliance Alert, December 19, 2007
The District of Columbia took one more step towards becoming the first jurisdiction to require pharmaceutical sales representatives to be licensed last week, The Washington Post reported.
The District council voted 7 to 6 to initially approve the SafeRX Act of 2007, which would require pharmaceutical sales representatives to be licensed by the D.C. Board of Pharmacy, be college graduates, follow a code of ethics, and refrain from providing gifts to physicians. The act also bans the use of prescribing data for marketing purposes unless a physician chooses to share his or her prescribing habits.
The Act must still pass a final vote on January 8, 2008.
Click here to read more in The Washington Post.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- HIPAA Q&A: Level of encryption needed for email
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- What does case-mix index mean to you?
- ED-to-inpatient transfers are flawed with safety gaps
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Searched